Research & Development Braeburn Pharmaceuticals Inc. / Office of Surveillance / SPONSOR PRESENTATIONS TITAN PHARMACEUTICALS INC. / Risk Management / Two Dreams Treatment System D / Chief Development Officer Titan Pharmaceuticals Inc. / Titan Pharmaceuticals Inc. / PhD / /
Facility
MD Segal Institute / Meeting FDA White Oak Campus / White Oak Conference Center / /
MedicalCondition
MS / /
Organization
Reproductive and Urologic Products Office / office of Medication Error Prevention / Psychopharmacologic Drugs Advisory Committee / office of New Drugs / FOOD AND DRUG ADMINISTRATION / Division of Anesthesia / Analgesia / and Addiction Products / Biostatistics office of Translational Sciences / TO ORDER AND INTRODUCTION OF COMMITTEE / Urologic Products Office / FDA / MS Statistics Reviewer Division of Biostatistics / Medication Error Prevention and Risk Management office of Surveillance / MPH Clinical Reviewer Division of Reproductive / Demand Reduction Office / Center for Drug Evaluation and Research / Division of Anesthesia / Division of Risk Management / Institute for Clinical Research Page / /
Person
Marc Rubin / Jason Bunting / Efficacy Kate Glassman-Beebe / Need Andrea Barthwell / Rachel Skeete / Garry Neil / Edward C. Covington / Celia Winchell / Barbara Wesley / Minh Doan / /
Position
CEO / Acting Designated Federal Officer / Clinical Team Leader / Deputy Director / Executive Chairman / Executive Vice President / Head / PharmD Risk Management Analyst / Chairperson / /
Microsoft Word - DRAFT Agenda PDAC[removed]doc